Adaptyv Bio runs an automated lab that takes digital protein sequences and returns experimental data on binding, expression and thermostability. It synthesizes DNA in-house. Customers submit designs through a web platform or through an API that AI agents can call directly, and the API is integrated with tools such as Boltz, Chai and Benchling. The company reports more than 100 customers, including frontier AI labs, Roche and Novo Nordisk.
Builder’s Brief
Adaptyv Bio is a research tool on Falcoscan. Automated wet lab that tests AI-designed proteins, ordered via web platform or API. Falcoscan rates Adaptyv Bio with an Opportunity score of 78/100, a Saturation score of 14/100, and a Wrapper-risk score of 15/100. Market signal: hot. Adaptyv Bio is founded in 2021, currently at Series_a stage. Pricing: Paid.
Market position · Research
How Adaptyv Bio compares in Research
Adaptyv Bio's opportunity score of 78 ranks #20 of 87 live Research tools on Falcoscan, 2.4 points above the category average of 75.6. Its saturation score is 14/100, against a category average of 14.3. 33 of the 87 live Research tools carry a hot signal, and Falcoscan has recorded 14 shutdowns in the category.
Adaptyv Bio compared with top-rated Research tools
The top-rated live Research tools on Falcoscan, other than Adaptyv Bio, are Altos Labs Bio AI, Biorender Scientific AI, Open Alex Research API, Anthropic Constitutional AI, and Undermind Research.
Is Adaptyv Bio still operating?
Yes. Falcoscan's operating checks list Adaptyv Bio as active.
Where is Adaptyv Bio based?
Adaptyv Bio is headquartered in Lausanne, Switzerland.
Does Adaptyv Bio have an API?
Yes. Adaptyv Bio offers an API.
Who is Adaptyv Bio for?
Adaptyv Bio is built for protein designers, ai labs, biotech companies, and pharma companies.